Delivery Order SPE2DB20D2014-SPE2DB25FB87H
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,858.30, is for the delivery of Daliresp 500 mcg tablets. It is a firm fixed-price delivery order contract with a performance period through March 17, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500mcg 90s medication. The contract has a ceiling value of $41,684.33 and a performance period through May 30, 2025. It is a firm-fixed-price delivery order contract, which indicates a pre-determined price for the medication. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,129.56, is for the supply of Daliresp 500 mcg tablets. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,890.98, is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price contract. No set-aside designation is mentioned. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Daliresp 500 mcg tablets. The contract has a ceiling value of $6,764.97 and a completion date of April 14, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Daliresp 500 mcg tablets. The contract has a ceiling value of $1,704.32 and runs through February 10, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,335.15, is for the delivery of DALIRESP 500 MCG TABLET 30S. It is a firm fixed-price contract with a completion date of December 30, 2024. The contract is not designated as a set-aside and appears to be an open competition award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,822.13 firm fixed price contract is for the delivery of Daliresp 500 mcg tablets, a medication used to treat chronic obstructive pulmonary disease (COPD). The award has an ultimate completion date of December 13, 2023. This contract is not designated as a set-aside....
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $2,877.41 contract is for the supply of the prescription drug Daliresp 500 mcg tablets. AmerisourceBergen, through its Corporate Office division, has a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $3,044.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,224 units of Daliresp 500 MCG tablets in a 90-count package. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance ending on May 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen...